Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The buyout is very important because it will "not" be based on the daily SP fluctuations or SP we see everyday. It will be based on the future of the company and all the new drugs coming soon. Companies are never bought for the current SP but what they will bring to the future of another company.Nasrat knows the true value of the company and so do all the other big pharma CEOs. It is only a matter of time before NasraT gets his asking price.
doncamel-I like your idea that Elite is buying back shares but I think there would have to be an announcement at some point. But, hey, go for it then announce buy back. Great thought you have. It would be nice.
Stealth accumulation. You won't see that reflected in the SP.
Elite and Nasrat will be able to use the same subjects that were used before. The trials are simply being redone and all the research centers and paperwork are in place. It seems a change in the thickness of the coating is all that is needed, not the coating itself. This will go quickly from the research end of things because they will not have to reinvent the wheel.
Stockboy- You have to start somewhere. Sooner or later all narcotics will be some form of Sequestox, even heroin. Sequestox is one small step for man and one giant leap for mankind.
Namtae- I agree. Insiders were brilliant in holding their shares. You got that right. Nice to see your support. .97 cents will look very cheap soon.
Total BS!!!!!
Sharkey1- Read down another 10 clicks and see SUN Pharm getting the same labeling. Good news. Means World-wide distribution.
Gman24- I totally agree with you. After reading Couch's post of the CC anyone who does not understand the positive implications of what was presented should not be investing in the OTC. Nasrat cannot just make things up and present false information or he will be on his way to jail. Yes, we must wait for Pfzer to get their drug on the market before we can follow on their coattails with our generic. Yes, it will take a little more time but taking more time does not take away from the true value of ELTP- it is just SOP.
The first miracle is that the size, weight, density, and color are the same but the drugs are different. The second miracle is that the naltrexone beads pass straight through but the opiate bead is utilized by the body yet the beads are identical by weight,size, color, and density. No other BigPharm comes even close to that.
In addition as I have mentioned many times, the SP is also misleading. Every evaluation done notes that ELTP is grossly undervalued. How could that be? Manipulation by MMs, shorts, dark pools,and hedge funds that has turned ELTP into a virtual ATM machine for them. It comes with the OTC territory and is par for the course on the OTC. Soon we will no longer be able to be manipulated through our R and D as well as getting FDA approval of many NDAs and ANDAs. It is this under evaluation and manipulation that is 25/8 taken advantage of and has constantly been fomented nonstop and mentioned ad nausem and repeated nonsensically with almost psychotic repetition.
ARBigguy- I think one thing is quite obvious. China needs to depend on American manufactoring. THis will help ELTP and is why we are starting two shifts. I think there will be more manufactoring on the way in addition to our own products.
aElmtPa- Thats the spirit. I agree.
There some posters here who keep drawing attention to the SP. They do this for two reasons: they want to buy and accumulate shares and they want everyone to sell their shares. Everyone knows when the FDA gives us the green light on anyone of 17 ELTP variations the SP will go up. This is the hardest lesson to learn on the OTC: THE SP MEANS NOTHING!!!!!! It is what it is for reasons of manipulation. In the time between the CRL and the FDA announcement their are people, MMs, dark pools, hedge funds, etc, etc who are buying every single share they can get their hands on. Their is not a lack of interest just a lack of shares and they do not want to raise the SP until they absolutely have to. Yes, it would be easy to raise the SP to buy more shares. But remember the MMs, etc are the meanest, greediest, tight fisted SOBs on the planet. They will keep forcing this down to buy more shares until the very last second they can get away with this and squeeze out every single share they can. They are doing this on many stocks at the same time. They put all these OTC stocks through the same "process" and they just keep rolling them off the line and picking them when they are ripe. Believe me, ELTP has been rolling along fine and they have made lots of money on ELTP.
Lasers- This is the best I can find:www.wddty.com and then look for current issue. Hope this helps.
November issue 2016 of "What Doctors Don't Tell You" are several illuminating articles about Califf and the FDA. First article "New FDA head in "pay of Big Pharma"" says Bernie Sanders; second article-"GSK fined for blocking antidepressant rivals" www.bbc.com/news/business-35557558 and the third article-" Independent cancer drug assessors(FDA) paid by Big Pharma"-JAMAInternMed;176:389-91.
Namtae- You keep forgetting that the SP means nothing. It is a manipulated SP by shorts, dark pools, and MMs. You cannot really assign any real true meaningful value to the SP. Mrmrw2020 and N2K are correct in that the true value of ELTP is far, far beyond the fake meaningless SP you see in front of you. Remember most of the buying of shares is done by MMs and dark pools and retail buyers actually buy a very small percentage of the total shares bought everyday.
I agree with N2K that ELTP cannot divulge any information as it relates to the FDA until the FDA has responded to their submission concerning the 3 steps that can be taken for Sequestox. Since they are backed up and only approving 2 new drugs per month then the FDA would not have responded yet to our submission for the 3 solutions for Sequestox. If the FDA has not responded how can Nasrat have any news that he can tell us. Just because we have to wait for the FDA does not mean ELTP is not doing anything for the future. In fact as time goes along then we have to get closer to an answer from the FDA. If I were Califf I would have a separate system and board to evaluate CRL letter responses once the first board has reviewed things that can take care of minor problems or infractions that need to be corrected to get the drug passed. No need for the original board to meet again over minor problems.
N2K- I just feel Califf is being overly cautious in an area where we desperately need help with opiate addiction. After all, the drugs we are using have been on the market for many years. People need help and Congress has been clamoring for help. It is just not an area where we have brand new drugs for which we should be cautious. I think he needs to be realistic and address the needs of this country and save lives. He should be bending over backwards trying to accommodate all drug companies of all sizes in drug addiction where this country needs real help. This should be his main focus. He also needs to get people off the board who have been roadblocks and who are in the back pocket of big pharms. They are so easy to spot. He must do better than 2 drugs per month or as I said he won't last long. He is suppose to be making the FDA more efficient, not overly cautious in an area where the drugs are well known. It is just a different package. Simple as that.
ELTP has many paths to getting SequestoxIR approved. As mentioned Nasrat has submitted 3 approaches already for the Tmax issue. In addition, ELTP getting an ER passed by the FDA will help grease the skids so to speak for the IR. If another company gets an IR approved then we can submit under an ANDA. If the Chinese or the Canadians approve Sequest IR outright that will put pressure on the FDA. So I see many paths to getting approval. Nasrat is continuing to work on submitting other ERs and is not just waiting on the IR anymore. Congress and public pressure will eventually make the FDA approve our IR. Also getting rid of some of the stupid and stubborn board members on the FDA will help. Even getting rid of Califf would be a big help. I think his tenure will be short. I am very happy with where we are in this process. Patience wins the day. Buy, hold , accumulate.
aELMTP-Good post. I totally agree.
There is absolutely positively nothing wrong with ELTP. We are just waiting on the FDA. MMs, hedge funds, shorts are constantly, nonstop, 24/7 putting downward pressure on ELTP to skim money off the top of ELTP. They are constantly bring up ridiculous accusations and conspiracy theories about ELTP. It is a play on human psychology- amazingly people would rather believe in conspiracy theories than the truth that is right in front of them as Couch so nicely has written this morning. It is boring to see the same BS everyday. ELTP has been an ATM machine for them and their illegal activities have gone unchecked which is par for the course in OTC land. They will do and say anything to keep their private ATM machine pumping out money.The FDA is far behind and I do not think Califf will last much longer. Patience, buy, hold, and wait on the FDA.
Steve- Yes, the purpose of this bid is to put a floor under ELTP while we wait for the FDA and to keep the MMs in line as much as can be done against naked shorting. MMs hate this guy. Yes, if MMs convince him to raise his bid to fill the order they will just drop it back down after they fill the order and collect the profit. If this were an honest system in OTC land that order would have been filled a long time ago. But he is asking for real shares - sometimes a problem in OTCland as was recently discussed in the article on covering naked shares.
rocioyogi- You are very observant.
CMDawg- I second that!!!
NAsrat is the best CEO we could have for ELTP. Others are making a mountain of discouraging posts during this waiting period which, of course, is the FDA as usual. Nasrat cannot control their schedule. Purdue and other BIgP are having the same issues, not just only ELTP. But Nasrat has anticipated these delays by building the generics up to the point that we will be self-sustaining while we work with the FDA over Sequestox. Additionally, Nasrat has chosen to work with the Chinese. THis was a clever move because it gets us around the FDA,it nullifies BIgP influence over the FDA, and puts great pressure on BigP. We are many years ahead of schedule as to where we would be with an ordinary CEO which is very upsetting for shorts, hedges, BigP, and MMs. I really like Nasrat's cost saving moves by following on the coattails of Purdue for many of our generic drugs which will be better than what Purdue will have come up with. But Purdue just got shot down on one of their drugs so that will delay ELTP also using Nasrats cost saving strategy. The future looks very bright but will take a little time. But whats new about that in the OTC world. As usual, others generate ridiculous posts over this time delay which is just routine business with the FDA for ELTP and all other BigP as well.
Nasrat will take the combined approach and push in all directions. He will push for Sequestox in China as part of Humanwell deal. He will push for our ER ADF following Purdue getting their go ahead. With revenue from China on Sequestox and revenue from our generic ER ADF as well as many others in line for approval capital gains will no longer be an issue. The FDA will look more and more foolish over time. BigPharma will lose the battle once China gives the green light for Sequestox. Whether the FDA has officially sanctioned Sequestox would be nice but not necessarily needed for a buyout if China approves it. For an American BigPharma to acquire ELTP will be very costly now. BigPharma has screwed themselves by playing these games. We will get a better deal from China where Sequestox is approved than BigPharma anyway.
Time to get rid of Califf, FDA Director. His decisions are a detriment and diametrically opposed to the health of Americans. His decisions are unfathomable and morally wrong in light of todays drug problems. He has made the problem worse not better. PFE still up to their old tricks. I hope Nasrat gets to testify on Capitol Hill over these recent FDA decisions. These decisions defy rational thinking.
Every bigphartma (t intentional there) company gets warning letters, etc. If you don't get warning letters your not accomplishing anything.
Exactly my point! It does not matter if we start in CHina first with Sequestox. FDA is slowly working themselves (by not working and making silly decisions based on nonsense) into being irrelevant. Why don't AMericans have the best medications possible? Because of the stupidity of the FDA and being subject to bribing by big Pharma. China is a bigger market and we should aim there first. You know, with Nasrats 30+ years in big Pharma I am sure he would have interesting testimony on Capital Hill in a Senate investigation as to what goes on at the FDA and why US citizens don't have the best medications available in the world. The FDA better wake up and realize this is an international market and they are becoming only a minor player. They are very far behind in even approving generics. The old bribing culture of the FDA will have to change to become relevant in a world market or they won't matter any more. Want Sequestox- Place your order in Canada or China on the internet.
We can postulate that the approval odds would be a little higher as implied by the aspirin analogy in Maz's statistics. That being the individual parts of Sequestox have already been approved by the FDA. So we are not quite inventing a new drug but reinventing the wheel so to speak or, at least, remanufacturing it. It is a little confusing because I think those stats applied to new drug submissions, not a recombination of old approved drugs. But that, in and of itself, is also a slight mystery that we were rejected over trivial Tmax and Cmax issues which affect all ANDAs and NDAs just the same. It is interesting that the only thing the FDA could come up with is the Tmax issue which is really for all intents and purposes, a non issue in my book and suggests, yes, we will get approved. Most likely, as Maz suggested, there is the influence of Big Pharma here. But the FDA in the end can say we have done all we can for you BigPharma to justify their bribe and it is inevitable that we have to approve Sequestox. With the involvement of the Chinese, pressure is mounting on BigPharma and the FDA. All Nasrat has to do is simply sell out to the Chinese, patents and all. They are perfectly capable of manufacturing Sequestox on their own in a bigger market. With all these outside factors altering the odds, I believe our problems will be resolved much sooner than later. The odds?-71%.
These are typical run of the mill posts designed to hide what is really going on. MMs are accumulating shares as fast as they can. They have a lot to cover. Posts that blame Nasrat, or this or that, are an effort to justify what is going on while they steal shares right and left and provide cover for what they are doing. They have to have some kind of explanation while they drive the SP down to accumulate shares.
That quick bear raid down to 16 will bail out most shorts who did a stupid move weeks ago before Nasrats annoucement. However, if that happens it will be so fast and will benefit only the choosen few and will be done for their benefit, not ours. We will not benefit from or see those shares.
Nasrat is not, absolutely not, pushing or antagonizing the FDA in the wrong way. In fact, Nasrat is trying to provide an easy way out for the FDA and trying to save them from their own stupidity. Nasrat has been in this business a long time and he knows exactly what goes on behind the scenes. He knows the FDA will have to give thumbs up for Sequestox. Even China is betting on it as well and will be pouring big bucks into ELTP.
Just remember Nasrat threw a fastball right down the alley for which the shorts, hedges, MMs were not prepared for. They just took a huge short position shortly before Nasrat tripped them up and they whiffed on the fastball. They are buried again. They will be very vicious with nonsensical posts and must drive the SP down no matter how many naked shares it takes. However, Nasrat, as I implied yesterday, has several more PRs coming, one of which is the 8K. These future PRs close at hand will keep shorts, hedges, and MMs buried, hopefully for good.
SHorts, hedge funds, and MMs are caught in a bind. Arbigguy's post was very significant in showing their was a massive increase in short shares just before Nasrat announced all the news with Human well/Puracap/Sungen. They are going to have to increase naked shorts and do their best to drive the SP down so these shorts caught with their shorts down can cover. Not a pretty picture. So we can expect a lot of FUD in the coming weeks. However, I think Nasrat has another surprise for the shorts in mind. Nasrat is going to get even with all the OTC run-of-the-mill stuff that goes on.
Hey Aqua- Stay safe!!
ARBIGGUy1- Thanks. Like I said Nasrat will bury shorts, hedge funds, and MMs. They will wish they never heard of ELTP.
To Nasrat: Please consider the military applications of our bead coating process. Thank you.
By adding the Chinese into the equation even more Nasrat does many good things. First it raises the buyout price because the CHinese can afford to pay a lot for ELTP. It puts indirectly more pressure on the FDA in that now the Chinese have the best ADFs and we don't due to the FDAs stupidity making their decision process look really bad in front of Congress and the public. We certainly do add to the bottom line making generics carry the day while Nasrat has to play footsies with the FDA and their silly games. I think Sequestox is going Chinese first and Nasrat wont think twice about it. Neither will the Chinese.